Thyme Care Raises Over $125M in Series E Funding Round Led by Morgan Health

Thyme Care, a prominent oncology company, secures over $125 million in new financing led by Morgan Health.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here